SCHEDULE 13G: Eventide Asset Management Discloses 6.7% Stake in Inventiva S.A.
Beneficial Ownership Disclosure
Eventide Asset Management, LLC, along with Finny Kuruvilla and Robin C. John, has disclosed a beneficial ownership of 6.7% of Inventiva S.A.'s Ordinary Shares.
Summary
- Eventide Asset Management, LLC, Finny Kuruvilla, M.D., Ph.D., and Robin C. John have jointly filed a Schedule 13G, reporting beneficial ownership of Inventiva S.A. Ordinary Shares.
- The aggregate amount beneficially owned by these reporting persons is 10,118,517 shares.
- This ownership represents 6.7% of the total outstanding Ordinary Shares of Inventiva S.A.
- Eventide Asset Management, LLC holds sole voting and sole dispositive power over all 10,118,517 shares.
- Finny Kuruvilla and Robin C. John each hold shared voting and shared dispositive power over the same 10,118,517 shares.
- Eventide Asset Management, LLC acts as the investment adviser to Eventide Healthcare Innovation Fund I LP, which is the entity directly holding these shares.
- The filing indicates that the securities were not acquired and are not held for the purpose of changing or influencing the control of Inventiva S.A.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently lead to a positive or negative sentiment regarding the company's performance or prospects.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of a significant passive investment stake by an asset management firm in a publicly traded company. It does not provide specific insights into broader industry trends or competitive landscape beyond the fact of the investment itself.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional investor holding 6.7% of shares may be viewed positively by other shareholders, indicating institutional confidence, though the filing explicitly states the investment is passive and not for control.
Key Dates
| Date | Description |
|---|---|
| 05/09/2025 | Date of event which requires the filing of this statement (ownership threshold crossed). |
| 05/14/2025 | Date the Schedule 13G statement was signed and filed. |
Keywords
Inventiva S.A., Eventide Asset Management, Schedule 13G, Beneficial Ownership, SEC Filing, Ordinary Shares, Investment Adviser, Healthcare Innovation Fund
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.